✦ LIBER ✦

Development of hepatocellular carcinoma in patients with chronic hepatitis C who had a sustained virological response to interferon therapy: a multicenter, retrospective cohort study of 1124 patients

✍ Scribed by S. Kobayashi; T. Takeda; M. Enomoto; A. Tamori; N. Kawada; D. Habu; H. Sakaguchi; T. Kuroda; K. Kioka; S. R. Kim; T. Kanno; T. Ueda; M. Hirano; S. Fujimoto; H. Jomura; S. Nishiguchi; S. Seki

Book ID: 111237609
Publisher: John Wiley and Sons
Year: 2007
Tongue: English
Weight: 91 KB
Volume: 27
Category: Article
ISSN: 0106-9543
DOI: 10.1111/j.1478-3231.2006.01406.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Characteristics of patients with chronic

Characteristics of patients with chronic hepatitis C who develop hepatocellular carcinoma after a sustained response to interferon therapy

✍ Akiko Makiyama; Yoshito Itoh; Akinori Kasahara; Yasuharu Imai; Sumio Kawata; Ken 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB 👁 3 views

## Abstract ## BACKGROUND The objective of the current study was to determine the characteristic features of sustained responders who develop hepatocellular carcinoma after treatment with interferon for chronic hepatitis C. ## METHODS This study included 3626 patients with chronic hepatitis C wh

Characteristics of patients with chronic

Characteristics of patients with chronic hepatitis C who develop hepatocellular carcinoma after a sustained response to interferon therapy

✍ Monica Basso; Francesco Torre; Antonino Picciotto 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 56 KB 👁 3 views

Risk factors for the development of hepa

Risk factors for the development of hepatocellular carcinoma among patients with chronic hepatitis C who achieved a sustained virological response to interferon therapy

✍ HAJIME TOKITA; HIDEO FUKUI; AKIHISA TANAKA; HIROSHI KAMITSUKASA; MICHIYASU YAGUR 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB

Risk factors for development of hepatoce

Risk factors for development of hepatocellular carcinoma in patients with chronic hepatitis C after sustained response to interferon

✍ Masafumi Ikeda; Shigetoshi Fujiyama; Motohiko Tanaka; Michio Sata; Tatsuya Ide; 📂 Article 📅 2005 🏛 Springer Japan 🌐 English ⚖ 185 KB

Reduced risk of hepatocellular carcinoma

Reduced risk of hepatocellular carcinoma after interferon therapy in aged patients with chronic hepatitis C is limited to sustained virological responders

✍ Y. Imai; S. Tamura; H. Tanaka; N. Hiramatsu; S. Kiso; Y. Doi; M. Inada; T. Nagas 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 157 KB

Effect of interferon therapy on the inci

Effect of interferon therapy on the incidence of hepatocellular carcinoma and mortality of patients with chronic hepatitis C: A retrospective cohort study of 738 patients

✍ Hideo Tanaka; Hideaki Tsukuma; Akinori Kasahara; Norio Hayashi; Harumasa Yoshiha 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 121 KB 👁 3 views